memapsin 2 inhibitors (Purdue University/Astellas)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namememapsin 2 inhibitors (Purdue University/Astellas)
Drug Alias NameGRL-11097
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAspartic acid proteases inhibitors
TargetsAspartic acid proteases
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A